App-Quantinova.ai

ATTENUATION IN PERIPHERAL ENDOTHELIAL FUNCTION AFTER CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE THERAPY IS ASSOCIATED WITH CARDIOVASCULAR ADVERSE EVENTS

Yasushi Matsuzawa - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

THE CLINICAL IMPACT OF ATRIAL FIBRILLATION IN PATIENTS WITH THE HEARTMATE II LEFT VENTRICULAR ASSIST DEVICE

Alan Enriquez - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

SHORT TERM ADVERSE EVENTS AND READMISSION RISK FOLLOWING PERCUTANEOUS CORONARY INTERVENTION IN AFRICAN-AMERICANS

Nevin Baker - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Lercanidipine hydrochloride

HEART ATTACKS TRIGGERED BY HUGE MUD SLIDES IN MOUNTAIN REGIONS AND SEVERE FLOODING IN INHABITED AREAS

Yasuhiro Nagayoshi - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

PARADIGM SHIFT IN THE TREATMENT OF PULMONARY EMBOLISM: SAFE DOSE THROMBOLYSIS PLUS RIVAROXABAN

Mohsen Sharifi - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Heparin

PERCUTANEOUS THROMBECTOMY WITH PRIMARY CORONARY RIGHT JUDKINS 8 FRENCH GUIDE FOR THE TREATMENT OF HIGH RISK ACUTE PULMONARY EMBOLISM HIGH RISK

Berumen Luis - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

ONE-YEAR CLINICAL OUTCOMES WITH BIODEGRADABLE POLYMER BIOLIMUS-ELUTING STENT IN PATIENTS WITH DIABETES MELLITUS: COMPARISON WITH DURABLE POLYMER EVEROLIMUS-ELUTING STENT

Shoichi Kuramitsu - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

VITAMIN D DEFICIENCY IS INDEPENDENTLY ASSOCIATED WITH THE EXTENT OF CORONARY ARTERY DISEASE

Monica Verdoia - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Ergocalciferol

IMPACT OF TOTAL STENT LENGTH ON 1-YEAR CLINICAL OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION WITH BIOLIMUS-ELUTING STENT AND EVEROLIMUS-ELUTING STENT

Takashi Hiromasa - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

CLOPIDOGREL RESISTANCE AND INTRA-STENT THROMBI ASSESSED BY OPTICAL COHERENCE TOMOGRAPHY AFTER DRUG-ELUTING STENT IMPLANTATION

Kenzo Fukuhara - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

LONG-TERM PROGNOSIS OF CORONARY ARTERY ANEURYSM DEVELOPING AFTER DRUG-ELUTING STENT IMPLANTATION

Hoyoun Won - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

ONE-YEAR CLINICAL OUTCOME OF BIOLIMUS-ELUTING STENT IN SMALL CORONARY ARTERIES COMPARED WITH EVEROLIMUS-ELUTING STENT

Hiroyuki Jinnouchi - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

ASPIRIN VERSUS CLOPIDOGREL FOLLOWING DUAL ANTIPLATELET THERAPY ON THE ERA OF DRUG-ELUTING STENTS

Taek Kyu Park - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

IS LIGHT TRANSMITTANCE AGGREGOMETRY STILL A USEFUL TOOL TO ASSESS PHARMACODYNAMIC EFFECTS OF ANTIPLATELET THERAPY?

Paul A. Gurbel - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

LONG-TERM CLINICAL IMPACT OF ACUTE STENT MALAPPOSITION: AN ADAPT-DES IVUS SUBSTUDY

Cristiano Souza - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

FOUR-YEAR OUTCOMES FOLLOWING RESOLUTE ZOTAROLIMUS-ELUTING STENT IMPLANTATION: RESOLUTE US STUDY

David Lee - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

ZoMaxx

LONG-TERM CLINICAL OUTCOMES OF EVEROLIMUS-ELUTING STENTS VERSUS SIROLIMUS-ELUTING STENTS IN PATIENTS WITH CORONARY ARTERY DISEASE: SORT OUT IV 4-YEAR

Lisette Okkels Jensen - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

IMPACT OF CONTRAST-INDUCED ACUTE KIDNEY INJURY AFTER CORONARY ANGIOGRAPHY OR PERCUTANEOUS CORONARY INTERVENTION ON LONG-TERM OUTCOMES: A POOLED ANALYSIS FROM THE HORIZONS-AMI AND ACUITY TRIALS

Daniele Giacoppo - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

ASPIRIN DESENSITIZATION IN PATIENTS WITH ACETYLSALICYLIC ACID SENSITIVITY: LONG TERM OUTCOME

Roberta Rossini - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Albyl-E

CLINICAL OUTCOME OF PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH BARE-METAL VERSUS DRUG-ELUTING STENTS: INSIGHTS FROM THE AFCAS REGISTRY

Marja Kaarina Puurunen - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Clopidogrel bisulfate

Filters

7277 Abstracts